CLINICAL ROLE -
Early Stages of Injectable PrEP Implant Show Promise in Complete Protection Against HIV
The latest data indicate that the formulation can provide up to 6 months of full protection against multiple virus challenges.
Read More
COVID-19 Infection Can Increase a Patient’s Risk of New-Onset Diabetes
The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.
Study Results Show COVID-19 Vaccination Uptake Is Suboptimal Among Veterans
Findings indicate that primary vaccines can be improved among younger, rural-dwelling individuals.
Investigators Encourage Naloxone Availability for Health Care Providers to Combat US Drug Epidemic
Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.
Female Patients Hospitalized With COVID-19 Are Less Likely to Have Cardiovascular Complications
Arrhythmia was found to be the most common cardiovascular complication of COVID-19.
Pharmacy Focus - Alternative Career Paths in PBMs
Matt Gibbs, president of Capital Rx, discusses alternative career paths in independently owned PBMs.
Listen
Extemporaneous Compounding of Amoxicillin Suspensions During National Shortage
As of November 2022, amoxicillin suspension has been on a national shortage list, therefore the FDA has permitted temporary compounding of amoxicillin suspensions.
Experts Discuss Need for Advocacy in Pharmacy, Health Care
This episode features Kathy Pham, PharmD, BCPPS, who discusses her experience at the American College of Clinical Pharmacy (ACCP) and why advocacy is important to health care and the pharmacy profession.
Watch
NCPA Video Series Helps Pharmacists Expand Their Practices
First season of makeover show follows 5 pharmacies building immunization programs.
FDA Advisory Committees Recommend Naloxone Be Available OTC
Although naloxone is already available without a prescription in all 50 states, not all pharmacies carry it and those that do must keep it behind the counter.
Teclistamab-cqyv Shows Promise in Relapsed/Refractory Multiple Myeloma Following 4 Prior Lines of Therapy
Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.
Study Results Show Declines in Continuity of Medication Use Among Adults With T2D
Declining and inconsistent use of blood-pressure, glucose-, and lipid-lowering medications for those with type 2 diabetes suggests treatment gaps, investigators say.
Blood Glucose Monitoring in Diabetes Care: When Innovation is Hidden In Plain Sight
Pharmacies have long embraced innovation and technology, with early adoption of telehealth and digital platforms.
Cardiorenal Events Account for Most Health Care Costs in Patients With Heart Failure
Patients with heart failure are at a significant risk of cardiorenal diseases, highlighting the need for improved treatments and cost management.
Regulatory T Cells May Influence Severity of COVID-19 Among Sexes
Link between male or female sex and the severity of COVID-19 may be found in a subset of regulatory T cells.
Irregular Sleep Patterns May Increase Risk of Arterial Plaque Buildup
More than 90 minutes of varied sleep time may also increase a person’s risk of developing hardened arteries.
Classification of Prostate Cancer Tumor Molecular Subtype Could Inform Treatment Response
New data identifying a particular gene expression signature will be presented at the 2023 ASCO Genitourinary Symposium.
Respect State Marijuana Laws Act of 2017 Amends Previous Legislation
Past proposal gives insight into lawmakers' thinking about medicinal use of cannabis on a federal level.
First Point-of-Care Test for Mpox Receives EUA From FDA
Under the EUA, the Xpert Mpox test is considered authorized for use in moderately complex point-of-care settings using the GeneXpert Xpress system.
Ousting the Pain: Migraine in University Students
Students may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.
Addition of Tremelimumab-actl to Durvalumab-Based Regimen May Broaden Clinical Activity in uHCC, mNSCLC
Both indications for the CTLA-4 inhibitor were approved by the FDA in 2022.
Stewardship Programs May Reduce Antibiotic Prescriptions, Consumption
Data from 52 studies show that antimicrobial stewardship programs largely reduced antibiotic use for pediatric care.
Personalized Oncology Can Profoundly Impact Patients Without Negatively Impacting Payers
The drive for personalized approaches to cancer have helped to create treatments for patients with rare cancers who have few, if any, options.
Study: Restricted Access To Abortion May Trigger Psychiatric Illness in Pregnant Individuals
Those seeking abortion were found to have triple the risk of a psychiatric disorder compared to the general population.
Pharmacists in Nontraditional Roles Are Not Included in Bureau of Labor Statistics Count of Working Pharmacists
Their exclusion ripples into demand estimates for pharmacists, leading to a distorted picture of pharmacist demand and, ultimately, impacting the number of individuals choosing to enter the profession.
Convenience, Effectiveness Prove Significant Attributes in Vaccine Uptake Decisions
US adults have a slightly stronger preference for fewer adverse events in relation to pediatric COVID-19 vaccination, study results show.
Idecabtagene Vicleucel Produces Significant Survival Improvement in Patients With Multiple Myeloma
Idecabtagene vicleucel prolonged progression-free survival by more than 1 year in a difficult-to-treat patient population with relapsed or refractory multiple myeloma.
Celebrating Black History Month: Organization Supports Black Health System Pharmacists
Association of Black Health-System Pharmacists focuses on advocacy, collaboration, education, leadership, and research.
Plan D Medicare Enrollees May Pay Slightly Higher Premium for Generics in 2023
Analysis shows average monthly premiums for stand-alone plans will rise 10% to $43.
Nirmatrelvir–Ritonavir Decreased Risk of Death in Patients at Risk of Severe Illness from COVID-19
Relative efficacy of nirmatrelvir–ritonavir appears similar across risk groups, but older adults at risk of severe COVID-19 may benefit more.